Search Orphan Drug Designations and Approvals
-
Generic Name: | glumetinib |
---|---|
Date Designated: | 01/25/2022 |
Orphan Designation: | Treatment of Non-small Cell Lung Cancer (NSCLC) with MET Genomic Aberration |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Haihe Biopharma Co., Ltd. No. 421 Newton Road Zhangjiang High-Tec Park, Pudong New District Shanghai 201203 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-